Vimarsana
Biggest News Aggregation in the World

Connor Bernstein News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Connor Bernstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Connor Bernstein Today - Breaking & Trending Today

Bionomics : Statutory Accounts - Form 6-K -September 29, 2023 at 10:53 am EDT - Vimarsana News

Bionomics : Statutory Accounts - Form 6-K -September 29, 2023 at 10:53 am EDT

Statutory Accounts Director's Report In accordance with the Corporations Act 2001, the directors of...

Quarterly Activities and Cashflow Report - Vimarsana News

Quarterly Activities and Cashflow Report

ADELAIDE, Australia, and CAMBRIDGE, Mass., July 31, 2023 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO), (Bionomics or the Company) a clinical-stage biopharmaceutical company developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need, today released its Appendix 4C – Quarterly Cashflow Report. Highlights during the Quarter ended 30 June 2023 (Quarter) a

Source: yahoo.com
Bionomics Announces Key Leadership Updates to Drive U.S.-Focused Transformation and Next Stage ... - Vimarsana News

Bionomics Announces Key Leadership Updates to Drive U.S.-Focused Transformation and Next Stage ...

Alan Fisher appointed Chair of the Board of DirectorsTim Cunningham joins as Chief Financial Officer

Bionomics Reports Topline Results in PREVAIL Phase 2 Study - Vimarsana News

Bionomics Reports Topline Results in PREVAIL Phase 2 Study

BNC210 for Treatment of Social Anxiety Disorder (SAD) Did Not Meet Primary EndpointSubjects with Confirmed SAD who Received BNC210 Exhibited Trends Toward...

Bionomics Limited Announces Pricing of Underwritten - Vimarsana News

Bionomics Limited Announces Pricing of Underwritten

ADELAIDE, Australia, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX: BNO, Nasdaq: BNOX), (“Bionomics” or the “Company”), a clinical-stage...